Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Non-Current Assets (2016 - 2018)

Armata Pharmaceuticals' Non-Current Assets history spans 6 years, with the latest figure at $5.5 million for Q3 2018.

  • For Q3 2018, Non-Current Assets fell 4.96% year-over-year to $5.5 million; the TTM value through Sep 2018 reached $22.5 million, down 36.11%, while the annual FY2017 figure was $5.8 million, 51.41% down from the prior year.
  • Non-Current Assets for Q3 2018 was $5.5 million at Armata Pharmaceuticals, down from $5.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $21.7 million in Q3 2014 and bottomed at $5.5 million in Q3 2018.
  • The 5-year median for Non-Current Assets is $21.1 million (2014), against an average of $15.1 million.
  • The largest annual shift saw Non-Current Assets rose 5.08% in 2014 before it tumbled 73.03% in 2017.
  • A 5-year view of Non-Current Assets shows it stood at $21.6 million in 2014, then fell by 0.38% to $21.5 million in 2015, then tumbled by 44.97% to $11.8 million in 2016, then plummeted by 51.41% to $5.8 million in 2017, then fell by 4.31% to $5.5 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Non-Current Assets are $5.5 million (Q3 2018), $5.6 million (Q2 2018), and $5.7 million (Q1 2018).